@benelong ,
Kudos to you; it appears they took on board your feedback in relation to providing details about how much they need to still spend on the trial.
What surprises me is that they only need US$13m to get to interim readout stage.
Which means Teva couldn't even be arsed to spend what would have been chump change to them to get to this important milestone.
Simply astonishing.
Ann: Update on Heart Failure Trial and Funding of Operations-MSB.AX, page-7
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$2.41 |
Change
0.620(34.6%) |
Mkt cap ! $3.084B | |||
| Open | High | Low | Value | Volume |
| $1.90 | $2.48 | $1.90 | $58.82M | 25.68M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 100915 | $2.40 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.41 | 99 | 1 |
View Market Depth
| Last trade - 16.12pm 18/07/2025 (20 minute delay) ? |
| MSB (ASX) Chart |